stockrowUnited Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.
- Revenue
- +4.13%
- EPS
- −21.7%
- Free cash flow
- −63.7%
Quarter to September 2026, against a year earlier
Follow UTHR
Alert me
United Therapeutics Corporation (UTHR) Operating margin
United Therapeutics Corporation's operating margin over the twelve months to 30 September 2026 was 41.5%, down 5.4 percentage points from fiscal 2025 (46.9%). Over the past ten years it has ranged from −13.0% (fiscal 2019) to 66.4% (fiscal 2016); the current reading is higher than 36% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 46.9% | (0.97) |
| FY2024 | 47.9% | (3.05) |
| FY2023 | 50.9% | 0.31 |
| FY2022 | 50.6% | 17.62 |
| FY2021 | 33.0% | (7.04) |
| FY2020 | 40.0% | 52.97 |
| FY2019 | −13.0% | (62.43) |
| FY2018 | 49.5% | 2.25 |
| FY2017 | 47.2% | (19.18) |
| FY2016 | 66.4% | 18.72 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 37.0% | (5.26) |
| Jun 2026 | 42.2% | 0.54 |
| Mar 2026 | 41.7% | (3.45) |
| Dec 2025 | 45.1% | (3.45) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| UTHR United Therapeutics Corporation | 41.5% |
| ZTS Zoetis Inc. compare | 37.1% |
| NBIX Neurocrine Biosciences, Inc. compare | 24.0% |
| HLN Haleon PLC Sponsored ADR compare | 17.9% |
| TAK Takeda Pharmaceutical Co. compare | 11.6% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 7.84% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| VTRS Viatris Inc. compare | −0.03% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on UTHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement